Ultragenyx Pharmaceutical (RARE) FY Conference Transcript

Ultragenyx Pharmaceutical (RARE) FY Conference June 10, 2025 10:00 AM ET Speaker0 Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're really pleased to have the Ultragenyx team with us where we have Emil Kakas, president and CEO, sitting next to me here. So to start, Emil, can you provide an overview of where the business stands today, including your portfolio of commercial products, but also your key priorities and pipeline outlook as you as you look to ...